Skip to main content
. Author manuscript; available in PMC: 2012 Apr 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Feb 4;252(2):150–158. doi: 10.1016/j.taap.2011.01.020

Figure 3.

Figure 3

Time course changes in Prdm1 expression levels in LPS-activated B cells. B cells were activated with LPS (10 μg/ml) and treated with TCDD (10 nM) or DMSO (0.02%). Prdm1 mRNA was analyzed by qRT-PCR at the indicated time. The data represent mean ± S.E. of quadruplicate measurements at each time-point of three experimental repliates. Comparisons were made between the LPS + TCDD-treated group and LPS + DMSO-treated group at each time point. *, p < 0.05.